All articles

Patient data belongs in the practice – not in a foreign cloud

Doctor documents findings at her desk

The easy route is rarely the secure one

Modern AI tools are tempting – but most send your data for processing to foreign data centres, often outside of Europe. With health data, this is a problem: as a practice, you bear the responsibility for the most confidential information a person has.

Confidentiality is not a detail

Medical confidentiality and the GDPR are not mere formalities, but the foundation of trust between patient and practice. As soon as data leaves the premises, you relinquish some of that control – and may not know where your data is located, who has access to it, and how long it is stored.

MedicalAI: local from the ground up

MedicalAI processes everything on-site, on our own infrastructure in Germany. There is no data processing by foreign cloud providers, no tracking and no hidden data sharing. Every access is logged, so it is always traceable who saw what and when.

This is how you fulfil your duty of care not just on paper – data protection is built into the system, not retrofitted.

Retain control – without sacrificing modern tools

Sovereignty and convenience are not mutually exclusive. With MedicalAI, you use modern AI in your daily practice and still retain full control over your data. The best of both worlds – without a poor compromise.

Conclusion

Health data belongs where it originates: in your practice. If you would like to know how MedicalAI implements this in concrete terms, please contact us. Contact

Frequently Asked Questions

Does patient data leave the practice?

No. MedicalAI processes and stores all data locally on our own infrastructure in Germany. There is no transfer to foreign clouds.

Is it GDPR compliant?

Yes. Local processing, access control, a complete log and the avoidance of tracking all support compliance with the GDPR from the outset.

Who can access the data?

Only authorised personnel in your practice – with role-based rights. Every access is logged for audit purposes.

This article first appeared on the blog of our partner Neuraxom.

Register now